Old and new facts about hyperthermia-induced modulations of the immune system

References

• Schildkopf P, Ott OJ, Frey B, Wadepohl M, Sauer R, Fietkau R, et al. Biological rationales and clinical applications of temperature controlled hyperthermia – Implications for multimodal cancer treatments. Curr Med Chem 2010; 17: 3045–3057
   PubMed Web of Science ®Google Scholar
• Hoption Cann SA, van Netten JP, van Netten C. Dr William Coley and tumour regression: A place in history or in the future. Postgrad Med J 2003; 79: 672–680
   PubMed Web of Science ®Google Scholar
• Berlin RD, Wood WB, Jr. Studies on the pathogenesis of fever. 13. The effect of phagocytosis on the release of endogenous pyrogen by polymorphonuclear leukocytes. J Exp Med 1964; 119: 715–726
   Google Scholar
• Duff GW, Durum SK. Fever and immunoregulation: Hyperthermia, interleukins 1 and 2, and T-cell proliferation. Yale J Biol Med 1982; 55: 437–442
   PubMed Web of Science ®Google Scholar
• Jampel HD, Duff GW, Gershon RK, Atkins E, Durum SK. Fever and immunoregulation. III. Hyperthermia augments the primary in vitro humoral immune response. J Exp Med 1983; 157: 1229–1238
   Google Scholar
• Redmann K, Burmeister J, Jenssen HL. The influence of hyperthermia on the transmembrane potential, zeta-potential and metabolism of polymorphonuclear leukocytes. Acta Biol Med Ger 1974; 33: 187–196
   PubMedGoogle Scholar
• Rosen P. Random repression, immunological surveillance and hyperthermia. Cancer Lett 1976; 2: 59–61
   PubMed Web of Science ®Google Scholar
• Goldenberg DM, Langner M. Direct and abscopal antitumor action of local hyperthermia. Z Naturforsch B 1971; 26: 359–361
   PubMedGoogle Scholar
• Colaco C. Function of fever. J R Soc Med 1997; 90: 587–588
   PubMed Web of Science ®Google Scholar
• Matzinger P. An innate sense of danger. Semin Immunol 1998; 10: 399–415
   PubMed Web of Science ®Google Scholar
• Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973; 137: 1142–1162
   Google Scholar
• Seong SY, Matzinger P. Hydrophobicity: An ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004; 4: 469–478
   PubMed Web of Science ®Google Scholar
• Schildkopf P, Frey B, Mantel F, Ott OJ, Weiss EM, Sieber R, et al. Application of hyperthermia in addition to ionizing irradiation fosters necrotic cell death and HMGB1 release of colorectal tumor cells. Biochem Biophys Res Commun 2010; 391: 1014–1020
   PubMed Web of Science ®Google Scholar
• Ljunggren HG, Karre K. In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today 1990; 11: 237–244
   PubMedGoogle Scholar
• Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000; 191: 423–434
   PubMed Web of Science ®Google Scholar
• Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 2000; 12: 1539–1546
   PubMed Web of Science ®Google Scholar
• Somersan S, Larsson M, Fonteneau JF, Basu S, Srivastava P, Bhardwaj N. Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. J Immunol 2001; 167: 4844–4852
   PubMed Web of Science ®Google Scholar
• Schueller G, Stift A, Friedl J, Dubsky P, Bachleitner-Hofmann T, Benkoe T, et al. Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells. Int J Oncol 2003; 22: 1397–1402
   PubMed Web of Science ®Google Scholar
• Wong JL, Mailliard RB, Moschos SJ, Edington H, Lotze MT, Kirkwood JM, et al. Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells. J Immunother 2011; 34: 270–278
   PubMed Web of Science ®Google Scholar
• Ferlazzo G, Pack M, Thomas D, Paludan C, Schmid D, Strowig T, et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA. 2004; 101: 16606–16611
   PubMed Web of Science ®Google Scholar
• Tomasovic SP, Klostergaard J. Hyperthermic modulation of macrophage-tumor cell interactions. Cancer Metastasis Rev 1989; 8: 215–229
   PubMed Web of Science ®Google Scholar
• Manzella JP, Roberts NJ, Jr. Human macrophage and lymphocyte responses to mitogen stimulation after exposure to influenza virus, ascorbic acid, and hyperthermia. J Immunol 1979; 123: 1940–1944
   PubMed Web of Science ®Google Scholar
• Postic B, DeAngelis C, Breinig MK, Monto HO. Effect of temperature on the induction of interferons by endotoxin and virus. J Bacteriol 1966; 91: 1277–1281
   PubMed Web of Science ®Google Scholar
• Skeen MJ, Olkowski ZL, DuPre JR, McLaren JR. Mitogenesis in human lymphocytes following brief exposure to hyperthermia. Int J Radiat Oncol Biol Phys 1983; 9: 61–66
   PubMed Web of Science ®Google Scholar
• von Ardenne M. Selective multiphase cancer therapy: Conceptual aspects and experimental basis. Adv Pharmacol Chemother 1972; 10: 339–380
   PubMedGoogle Scholar
• Ostberg JR, Patel R, Repasky EA. Regulation of immune activity by mild (fever-range) whole body hyperthermia: Effects on epidermal Langerhans cells. Cell Stress Chaperones 2000; 5: 458–461
   PubMed Web of Science ®Google Scholar
• Peng JC, Hyde C, Pai S, O'sullivan BJ, Nielsen LK, Thomas R. Monocyte-derived DC primed with TLR agonists secrete IL-12p70 in a CD40-dependent manner under hyperthermic conditions. J Immunother 2006; 29: 606–615
   PubMed Web of Science ®Google Scholar
• Yan X, Xiu F, An H, Wang X, Wang J, Cao X. Fever range temperature promotes TLR4 expression and signaling in dendritic cells. Life Sci 2007; 80: 307–313
   PubMed Web of Science ®Google Scholar
• Wang WC, Goldman LM, Schleider DM, Appenheimer MM, Subjeck JR, Repasky EA, et al. Fever-range hyperthermia enhances L-selectin-dependent adhesion of lymphocytes to vascular endothelium. J Immunol 1998; 160: 961–969
   PubMed Web of Science ®Google Scholar
• Evans SS, Wang WC, Bain MD, Burd R, Ostberg JR, Repasky EA. Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules. Blood 2001; 97: 2727–2733
   PubMed Web of Science ®Google Scholar
• Azocar J, Yunis EJ, Essex M. Sensitivity of human natural killer cells to hyperthermia. Lancet 1982; 1: 16–17
   PubMed Web of Science ®Google Scholar
• Zanker KS, Lange J. Whole body hyperthermia and natural killer cell activity. Lancet 1982; 1: 1079–1080
   PubMed Web of Science ®Google Scholar
• Shen RN, Hornback NB, Shidnia H, Shupe RE, Brahmi Z. Whole-body hyperthermia decreases lung metastases in lung tumor-bearing mice, possibly via a mechanism involving natural killer cells. J Clin Immunol 1987; 7: 246–253
   PubMed Web of Science ®Google Scholar
• Burd R, Dziedzic TS, Xu Y, Caligiuri MA, Subjeck JR, Repasky EA. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J Cell Physiol 1998; 177: 137–147
   PubMed Web of Science ®Google Scholar
• Hattori T, Kokura S, Okuda T, Okayama T, Takagi T, Handa O, et al. Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer. Int J Hyperthermia 2007; 23: 591–598
   PubMed Web of Science ®Google Scholar
• Dayanc BE, Beachy SH, Ostberg JR, Repasky EA. Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses. Int J Hyperthermia 2008; 24: 41–56
   PubMed Web of Science ®Google Scholar
• Takada Y, Sato EF, Nakajima T, Hosono M, Tsumura M, Inoue M, et al. Granulocyte-colony stimulating factor enhances anti-tumour effect of hyperthermia. Int J Hyperthermia 2000; 16: 275–286
   PubMed Web of Science ®Google Scholar
• Kokura S, Yoshikawa T, Tainaka K, Kaneko T, Iinuma S, Nishimura S, et al. Anti-tumor effects of hyperthermia plus granulocyte colony-stimulating factor. Jpn J Cancer Res 1996; 87: 862–866
   PubMedGoogle Scholar
• Buhring M, Bork-Wolwer L, Krippner H, Pirlet K. Quantitative Veränderungen an peripheren T-Lymphozyten während der Hyperthermie [Quantitative changes in peripheral T-lymphocytes during hyperthermia (trans. author)]. MMW Munch Med Wochenschr 1977; 119: 1591–1594
   PubMedGoogle Scholar
• Grogan JB, Parks LC, Minaberry D. Polymorphonuclear leukocyte function in cancer patients treated with total body hyperthermia. Cancer 1980; 45: 2611–2615
   PubMed Web of Science ®Google Scholar
• Rama Rao G, Cain CA, Lockwood J, Tompkins WA. Effects of microwave exposure on the hamster immune system. II. Peritoneal macrophage function. Bioelectromagnetics 1983; 4: 141–155
   PubMed Web of Science ®Google Scholar
• Harris JW, Meneses JJ. Effects of hyperthermia on the production and activity of primary and secondary cytolytic T-lymphocytes in vitro. Cancer Res 1978; 38: 1120–1126
   PubMed Web of Science ®Google Scholar
• Shah SA, Dickson JA. Effect of hyperthermia on the immune response of normal rabbits. Cancer Res 1978; 38: 3518–3522
   PubMed Web of Science ®Google Scholar
• Fuggetta MP, Alvino E, Tricarico M, D’Atri S, Pepponi R, Prete SP, et al. In vitro effect of hyperthermia on natural cell-mediated cytotoxicity. Anticancer Res 2000; 20: 1667–1672
   PubMed Web of Science ®Google Scholar
• Yang H, Lauzon W, Lemaire I. Effects of hyperthermia on natural killer cells: Inhibition of lytic function and microtubule organization. Int J Hyperthermia 1992; 8: 87–97
   PubMed Web of Science ®Google Scholar
• Schildkopf P, Frey B, Ott OJ, Rubner Y, Multhoff G, Sauer R, et al. Radiation combined with hyperthermia induces Hsp70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages. Radiother Oncol 2011; 101: 109–115
   PubMed Web of Science ®Google Scholar
• Liburdy RP. Radiofrequency radiation alters the immune system: Modulation of T- and B-lymphocyte levels and cell-mediated immunocompetence by hyperthermic radiation. Radiat Res 1979; 77: 34–46
   PubMed Web of Science ®Google Scholar
• Alfieri AA, Hahn EW, Kim JH. Role of cell-mediated immunity in tumor eradication by hyperthermia. Cancer Res 1981; 41: 1301–1305
   PubMed Web of Science ®Google Scholar
• Shah SA. Participation of the immune system in regression of a rat Mc7 sarcoma by hyperthermia. Cancer Res 1981; 41: 1742–1747
   PubMed Web of Science ®Google Scholar
• Dickson JA, Shah SA. Hyperthermia: The immune response and tumor metastasis. Natl Cancer Inst Monogr 1982; 61: 183–192
   PubMedGoogle Scholar
• Cippitelli M, Fionda C, Di Bona D, Piccoli M, Frati L, Santoni A. Hyperthermia enhances CD95-ligand gene expression in T lymphocytes. J Immunol 2005; 174: 223–232
   PubMed Web of Science ®Google Scholar
• Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002; 20: 323–370
   PubMed Web of Science ®Google Scholar
• Park MM, Hornback NB, Endres S, Dinarello CA. The effect of whole body hyperthermia on the immune cell activity of cancer patients. Lymphokine Res 1990; 9: 213–223
   PubMedGoogle Scholar
• Ostberg JR, Repasky EA. Comparison of the effects of two different whole body hyperthermia protocols on the distribution of murine leukocyte populations. Int J Hyperthermia 2000; 16: 29–43
   PubMed Web of Science ®Google Scholar
• Ostberg JR, Gellin C, Patel R, Repasky EA. Regulatory potential of fever-range whole body hyperthermia on Langerhans cells and lymphocytes in an antigen-dependent cellular immune response. J Immunol 2001; 167: 2666–2670
   PubMed Web of Science ®Google Scholar
• Skitzki JJ, Repasky EA, Evans SS. Hyperthermia as an immunotherapy strategy for cancer. Curr Opin Investig Drugs 2009; 10: 550–558
   PubMed Web of Science ®Google Scholar
• Overgaard K, Overgaard J. Investigation on the possibility of a thermic tumour therapy. II. Action of combined heat-roentgen treatment on a transplanted mouse mammary carcinoma. Eur J Cancer 1972; 8: 573–575
   Google Scholar
• Cavaliere R, Ciocatto EC, Giovanella BC, Heidelberger C, Johnson RO, Margottini M, et al. Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer 1967; 20: 1351–1381
   Google Scholar
• Suzuki M, Shinkai M, Honda H, Kobayashi T. Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes. Melanoma Res 2003; 13: 129–135
   PubMed Web of Science ®Google Scholar
• Mondovi B, Santoro AS, Strom R, Faiola R, Fanelli AR. Increased immunogenicity of Ehrlich ascites cells after heat treatment. Cancer 1972; 30: 885–888
   PubMed Web of Science ®Google Scholar
• Schechter M, Stowe SM, Moroson H. Effects of hyperthermia on primary and metastatic tumor growth and host immune response in rats. Cancer Res 1978; 38: 498–502
   PubMed Web of Science ®Google Scholar
• Davies CD, Lindmo T. Hyperthermia-induced shedding and masking of melanoma-associated antigen. Int J Hyperthermia 1990; 6: 1053–1064
   PubMed Web of Science ®Google Scholar
• Schildkopf P, Holmer R, Sieber R, Ott OJ, Janko C, Mantel F, et al. Hyperthermia in combination with X-irradiation induces inflammatory forms of cell death. Autoimmunity 2009; 42: 311–313
   PubMed Web of Science ®Google Scholar
• Shi H, Cao T, Connolly JE, Monnet L, Bennett L, Chapel S, et al. Hyperthermia enhances CTL cross-priming. J Immunol 2006; 176: 2134–2141
   PubMed Web of Science ®Google Scholar
• Agarwal SS, Katz EJ, Loeb LA. Effect of hyperthermia on the survival of normal human peripheral blood mononuclear cells. Cancer Res 1983; 43: 3124–3126
   PubMed Web of Science ®Google Scholar
• Johnston RL, Rao GR, Tompkins WA, Cain CA. Effects of in vivo ultrasound hyperthermia on natural killer cell cytotoxicity in the hamster. Bioelectromagnetics 1986; 7: 283–293
   PubMed Web of Science ®Google Scholar
• Harada H, Murakami T, Tea SS, Takeuchi A, Koga T, Okada S, et al. Heat shock suppresses human NK cell cytotoxicity via regulation of perforin. Int J Hyperthermia 2007; 23: 657–665
   PubMed Web of Science ®Google Scholar
• Roberts NJ, Jr. Differential effects of hyperthermia on human leukocyte production of interferon-alpha and interferon-gamma. Proc Soc Exp Biol Med 1986; 183: 42–47
   PubMed Web of Science ®Google Scholar
• Borkamo ED, Dahl O, Bruland O, Fluge O. Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor. Int J Hyperthermia 2009; 25: 41–46
   PubMed Web of Science ®Google Scholar
• Moore TC, Nur K, Storm FK. Localized deep hyperthermia increases the traffic of lymphocytes through peripheral lymph nodes of sheep in vivo. J Surg Oncol 1987; 35: 75–81
   PubMed Web of Science ®Google Scholar
• Yoshioka A, Miyachi Y, Toda K, Imamura S, Hiraoka M, Abe M. Effects of local hyperthermia on natural killer activity in mice. Int J Hyperthermia 1990; 6: 261–267
   PubMed Web of Science ®Google Scholar
• Mitsudo K, Kobayashi M, Tohnai I, Ueda M, Kotani H, Hoshino T. Electron-microscopic and immunohistochemical studies of Langerhans cells and Thy-1-positive cells in mouse tongue epithelium subjected to local hyperthermia. Arch Oral Biol 1995; 40: 533–538
   PubMed Web of Science ®Google Scholar
• Bruggmoser G, Bauchowitz S, Canters R, Crezee H, Ehmann M, Gellermann J, et al. Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol 2011; 187: 605–610
   PubMed Web of Science ®Google Scholar
• Milani V, Noessner E. Effects of thermal stress on tumor antigenicity and recognition by immune effector cells. Cancer Immunol Immunother 2006; 55: 312–319
   PubMed Web of Science ®Google Scholar
• Beachy SH, Repasky EA. Toward establishment of temperature thresholds for immunological impact of heat exposure in humans. Int J Hyperthermia 2011; 27: 344–352
   PubMed Web of Science ®Google Scholar
• Sciandra JJ, Subjeck JR. Heat shock proteins and protection of proliferation and translation in mammalian cells. Cancer Res 1984; 44: 5188–5194
   PubMed Web of Science ®Google Scholar
• Nylandsted J, Gyrd-Hansen M, Danielewicz A, Fehrenbacher N, Lademann U, Hoyer-Hansen M, et al. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med 2004; 200: 425–435
   PubMed Web of Science ®Google Scholar
• Jaattela M, Wissing D. Heat-shock proteins protect cells from monocyte cytotoxicity: Possible mechanism of self-protection. J Exp Med 1993; 177: 231–236
   PubMed Web of Science ®Google Scholar
• Ciocca DR, Fanelli MA, Cuello-Carrion FD, Castro GN. Heat shock proteins in prostate cancer: From tumorigenesis to the clinic. Int J Hyperthermia 2010; 26: 737–747
   PubMed Web of Science ®Google Scholar
• Baronzio G, Gramaglia A, Fiorentini G. Hyperthermia and immunity. A brief overview. In Vivo 2006; 20: 689–695
   Google Scholar
• Hannani D, Sistigu A, Kepp O, Galluzzi L, Kroemer G, Zitvogel L. Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy. Cancer J 2011; 17: 351–358
   PubMed Web of Science ®Google Scholar
• Srivastava PK. Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens. Methods 1997; 12: 165–171
   PubMed Web of Science ®Google Scholar
• Hantschel M, Pfister K, Jordan A, Scholz R, Andreesen R, Schmitz G, et al. Hsp70 plasma membrane expression on primary tumor biopsy material and bone marrow of leukemic patients. Cell Stress Chaperones 2000; 5: 438–442
   PubMed Web of Science ®Google Scholar
• Gehrmann M, Marienhagen J, Eichholtz-Wirth H, Fritz E, Ellwart J, Jaattela M, et al. Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: Protection against radiation-induced effects and target structure for natural killer cells. Cell Death Differ 2005; 12: 38–51
   PubMed Web of Science ®Google Scholar
• Multhoff G. Heat shock protein 72 (Hsp72), a hyperthermia-inducible immunogenic determinant on leukemic K562 and Ewing's sarcoma cells. Int J Hyperthermia 1997; 13: 39–48
   PubMed Web of Science ®Google Scholar
• Hurwitz MD, Kaur P, Nagaraja GM, Bausero MA, Manola J, Asea A. Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer. Radiother Oncol 2010; 95: 350–358
   PubMed Web of Science ®Google Scholar
• Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M, Vile RG. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med 1998; 4: 581–587
   PubMed Web of Science ®Google Scholar
• Binder RJ, Blachere NE, Srivastava PK. Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules. J Biol Chem 2001; 276: 17163–17171
   PubMed Web of Science ®Google Scholar
• Suto R, Srivastava PK. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 1995; 269: 1585–1588
   PubMed Web of Science ®Google Scholar
• Menoret A, Chaillot D, Callahan M, Jacquin C. Hsp70, an immunological actor playing with the intracellular self under oxidative stress. Int J Hyperthermia 2002; 18: 490–505
   PubMed Web of Science ®Google Scholar
• Baler R, Zou J, Voellmy R. Evidence for a role of Hsp70 in the regulation of the heat shock response in mammalian cells. Cell Stress Chaperones 1996; 1: 33–39
   PubMed Web of Science ®Google Scholar
• Calderwood SK, Theriault JR, Gong J. How is the immune response affected by hyperthermia and heat shock proteins?. Int J Hyperthermia 2005; 21: 713–716
   PubMed Web of Science ®Google Scholar
• Calderwood SK, Theriault JR, Gong J. Message in a bottle: Role of the 70-kDa heat shock protein family in anti-tumor immunity. Eur J Immunol 2005; 35: 2518–2527
   PubMed Web of Science ®Google Scholar
• Mambula SS, Calderwood SK. Heat induced release of Hsp70 from prostate carcinoma cells involves both active secretion and passive release from necrotic cells. Int J Hyperthermia 2006; 22: 575–585
   PubMed Web of Science ®Google Scholar
• Milani V, Noessner E, Ghose S, Kuppner M, Ahrens B, Scharner A, et al. Heat shock protein 70: Role in antigen presentation and immune stimulation. Int J Hyperthermia 2002; 18: 563–575
   PubMed Web of Science ®Google Scholar
• Gehrmann M, Liebisch G, Schmitz G, Anderson R, Steinem C, De Maio A, et al. Tumor-specific Hsp70 plasma membrane localization is enabled by the glycosphingolipid Gb3. PLoS One 2008; 3: e1925
   PubMed Web of Science ®Google Scholar
• Frey B, Gaipl US. The immune functions of phosphatidylserine in membranes of dying cells and microvesicles. Semin Immunopathol 2011; 33: 497–516
   PubMed Web of Science ®Google Scholar
• Elsner L, Muppala V, Gehrmann M, Lozano J, Malzahn D, Bickeboller H, et al. The heat shock protein Hsp70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands. J Immunol 2007; 179: 5523–5533
   PubMed Web of Science ®Google Scholar
• Chen T, Guo J, Yang M, Zhu X, Cao X. Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine. J Immunol 2011; 186: 2219–2228
   PubMed Web of Science ®Google Scholar
• Multhoff G. Activation of natural killer cells by heat shock protein 70. 2002, 18: 576–585, Comment: Int J Hyperthermia 2009;25:169–175
   Google Scholar
• Torigoe T, Tamura Y, Sato N. Heat shock proteins and immunity: Application of hyperthermia for immunomodulation. Int J Hyperthermia 2009; 25: 610–616
   PubMed Web of Science ®Google Scholar
• Polier S, Dragovic Z, Hartl FU, Bracher A. Structural basis for the cooperation of Hsp70 and Hsp110 chaperones in protein folding. Cell 2008; 133: 1068–1079
   PubMed Web of Science ®Google Scholar
• Wang XY, Kazim L, Repasky EA, Subjeck JR. Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. J Immunol 2001; 166: 490–497
   PubMed Web of Science ®Google Scholar
• Di YP, Repasky EA, Subjeck JR. Distribution of Hsp70, protein kinase C, and spectrin is altered in lymphocytes during a fever-like hyperthermia exposure. J Cell Physiol 1997; 172: 44–54
   PubMed Web of Science ®Google Scholar
• Knippertz I, Stein MF, Dorrie J, Schaft N, Muller I, Deinzer A, et al. Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies. Int J Hyperthermia 2011; 27: 591–603
   PubMed Web of Science ®Google Scholar
• Basu S, Srivastava PK. Fever-like temperature induces maturation of dendritic cells through induction of Hsp90. Int Immunol 2003; 15: 1053–1061
   PubMed Web of Science ®Google Scholar
• Wang J, Koyama S, Komatsubara Y, Suzuki Y, Taki M, Miyakoshi J. Effects of a 2450 MHz high-frequency electromagnetic field with a wide range of SARs on the induction of heat-shock proteins in A172 cells. Bioelectromagnetics 2006; 27: 479–486
   PubMed Web of Science ®Google Scholar
• Stangl S, Gross C, Pockley AG, Asea AA, Multhoff G. Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells. Cell Stress Chaperones 2008; 13: 221–230
   PubMed Web of Science ®Google Scholar
• Gastpar R, Gehrmann M, Bausero MA, Asea A, Gross C, Schroeder JA, et al. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res 2005; 65: 5238–5247
   PubMed Web of Science ®Google Scholar
• Michaelsson J, Teixeira de Matos C, Achour A, Lanier LL, Karre K, Soderstrom K. A signal peptide derived from Hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J Exp Med 2002; 196: 1403–1414
   PubMed Web of Science ®Google Scholar
• Qiao Y, Liu B, Li Z. Activation of NK cells by extracellular heat shock protein 70 through induction of NKG2D ligands on dendritic cells. Cancer Immun 2008; 8: 12
   PubMedGoogle Scholar
• van der Zee J. Heating the patient: A promising approach?. Ann Oncol 2002; 13: 1173–1184
   PubMed Web of Science ®Google Scholar
• Song CW, Shakil A, Osborn JL, Iwata K. Tumour oxygenation is increased by hyperthermia at mild temperatures. 1996, 12: 367–373, Int J Hyperthermia 2009;25:91–95
   Google Scholar
• Iliakis G, Wu W, Wang M. DNA double strand break repair inhibition as a cause of heat radiosensitization: Re-evaluation considering backup pathways of NHEJ. Int J Hyperthermia 2008; 24: 17–29
   PubMed Web of Science ®Google Scholar
• Krawczyk PM, Eppink B, Essers J, Stap J, Rodermond H, Odijk H, et al. Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition. Proc Natl Acad Sci USA. 2011; 108: 9851–9856
   PubMed Web of Science ®Google Scholar
• Tompkins WA, Rama Rao GV, Pantasatos P, Cain CA. Hyperthermia enhancement of antibody-complement cytotoxicity for human colon tumor cells. J Natl Cancer Inst 1981; 66: 453–459
   PubMedGoogle Scholar
• Mise K, Kan N, Okino T, Nakanishi M, Satoh K, Teramura Y, et al. Effect of heat treatment on tumor cells and antitumor effector cells. Cancer Res 1990; 50: 6199–6202
   PubMed Web of Science ®Google Scholar
• Shelton SN, Dillard CD, Robertson JD. Activation of caspase-9, but not caspase-2 or caspase-8, is essential for heat-induced apoptosis in Jurkat cells. J Biol Chem 2010; 285: 40525–40533
   PubMed Web of Science ®Google Scholar
• Mantel F, Frey B, Haslinger S, Schildkopf P, Sieber R, Ott OJ, et al. Combination of ionising irradiation and hyperthermia activates programmed apoptotic and necrotic cell death pathways in human colorectal carcinoma cells. Strahlenther Onkol 2010; 186: 587–599
   PubMed Web of Science ®Google Scholar
• Kawai N, Ito A, Nakahara Y, Futakuchi M, Shirai T, Honda H, et al. Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune-response induction in transplanted syngeneic rats. Prostate 2005; 64: 373–381
   PubMed Web of Science ®Google Scholar
• Muckle DS, Dickson JA. Hyperthermia (42 degrees C) as an adjuvant to radiotherapy and chemotherapy in the treatment of the allogeneic VX2 carcinoma in the rabbit. Br J Cancer 1973; 27: 307–315
   PubMed Web of Science ®Google Scholar
• Muckle DS, Dickson JA. The selective inhibitory effect of hyperthermia on the metabolism and growth of malignant cells. Br J Cancer 1971; 25: 771–778
   PubMed Web of Science ®Google Scholar
• Elkon D, Fechner RE, Homzie MJ, Baker DG, Constable WC. Response of mouse kidney to hyperthermia: Pathology and temperature-dependence of injury. Arch Pathol Lab Med 1980; 104: 153–158
   PubMed Web of Science ®Google Scholar
• Ito A, Honda H, Kobayashi T. Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: A novel concept of ‘heat-controlled necrosis’ with heat shock protein expression. Cancer Immunol Immunother 2006; 55: 320–328
   PubMed Web of Science ®Google Scholar
• Tang D, Kang R, Zeh HJ, III, Lotze MT. High-mobility group box 1 and cancer. Biochim Biophys Acta 2010; 1799: 131–140
   PubMed Web of Science ®Google Scholar
• Yerushalmi A, Weinstein Y. Stimulation of resistance to tumor growth of athymic nude mice pretreated by combined local hyperthermia and X-irradiation. Cancer Res 1979; 39: 1126–1128
   PubMed Web of Science ®Google Scholar
• Roszkowski W, Wrembel JK, Roszkowski K, Janiak M, Szmigielski S. Does whole-body hyperthermia therapy involve participation of the immune system?. Int J Cancer 1980; 25: 289–292
   PubMed Web of Science ®Google Scholar
• Robins HI. Role of whole-body hyperthermia in the treatment of neoplastic disease: Its current status and future prospects. Cancer Res 1984; 44: S4878–4883
   Web of Science ®Google Scholar
• Gridley DS, Nutter RL, Kettering JD, Mantik DW, Slater JM. Mouse neoplasia and immunity: Effects of radiation, hyperthermia, 2-deoxy-D-glucose, and Corynebacterium parvum. Oncology 1985; 42: 391–398
   PubMed Web of Science ®Google Scholar
• Issels RD. Hyperthermia adds to chemotherapy. Eur J Cancer 2008; 44: 2546–2554
   PubMed Web of Science ®Google Scholar
• Shen RN, Lu L, Wu B, Shidnia H, Hornback NB, Broxmeyer HE. Effects of interleukin 2 treatment combined with local hyperthermia in mice inoculated with Lewis lung carcinoma cells. Cancer Res 1990; 50: 5027–5030
   PubMed Web of Science ®Google Scholar
• Wu B, Shen RN, Wang WX, Broxmeyer HE, Lu L. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells. Stem Cells 1993; 11: 412–421
   PubMed Web of Science ®Google Scholar
• Geehan DM, Fabian DF, Lefor AT. Local hyperthermia abrogates the anti-immunotherapeutic effect of interleukin-8. J Surg Oncol 1994; 56: 102–106
   PubMed Web of Science ®Google Scholar
• Klostergaard J, Barta M, Tomasovic SP. Hyperthermic modulation of tumor necrosis factor-dependent monocyte/macrophage tumor cytotoxicity in vitro. J Biol Response Mod 1989; 8: 262–277
   PubMedGoogle Scholar
• Tomasovic SP, Barta M, Klostergaard J. Temporal dependence of hyperthermic augmentation of macrophage-TNF production and tumor cell-TNF sensitization. Int J Hyperthermia 1989; 5: 625–639
   PubMed Web of Science ®Google Scholar
• Srinivasan JM, Fajardo LF, Hahn GM. Mechanism of antitumor activity of tumor necrosis factor alpha with hyperthermia in a tumor necrosis factor alpha-resistant tumor. J Natl Cancer Inst 1990; 82: 1904–1910
   PubMedGoogle Scholar
• Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13: 1050–1059
   PubMed Web of Science ®Google Scholar
• Miller RC, Roizin-Towle L, Komatsu K, Richards M, Hall EJ. Interaction of heat with X-rays and cis-platinum: Cell lethality and oncogenic transformation. Int J Hyperthermia 1989; 5: 697–705
   PubMed Web of Science ®Google Scholar
• Baker D, Sager H, Constable W. The influence of levamisole and hyperthermia on the incidence of metastases from an X-irradiated tumor. Cancer Invest 1986; 4: 287–292
   PubMed Web of Science ®Google Scholar
• Morita M, Kuwano H, Araki K, Egashira A, Kawaguchi H, Saeki H, et al. Prognostic significance of lymphocyte infiltration following preoperative chemoradiotherapy and hyperthermia for esophageal cancer. Int J Radiat Oncol Biol Phys 2001; 49: 1259–1266
   PubMed Web of Science ®Google Scholar
• Guo J, Zhu J, Sheng X, Wang X, Qu L, Han Y, et al. Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma. Int J Cancer 2007; 120: 2418–2425
   PubMed Web of Science ®Google Scholar
• Mukhopadhaya A, Mendecki J, Dong X, Liu L, Kalnicki S, Garg M, et al. Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity. Cancer Res 2007; 67: 7798–7806
   PubMed Web of Science ®Google Scholar
• Tanaka K, Ito A, Kobayashi T, Kawamura T, Shimada S, Matsumoto K, et al. Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles. Int J Cancer 2005; 116: 624–633
   PubMed Web of Science ®Google Scholar
• Bachleitner-Hofmann T, Strohschneider M, Krieger P, Sachet M, Dubsky P, Hayden H, et al. Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma. J Clin Endocrinol Metab 2006; 91: 4571–4577
   PubMed Web of Science ®Google Scholar
• Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L, et al. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys 2004; 58: 862–870
   PubMed Web of Science ®Google Scholar
• Chakravarty PK, Guha C, Alfieri A, Beri V, Niazova Z, Deb NJ, et al. Flt3L therapy following localized tumor irradiation generates long-term protective immune response in metastatic lung cancer: Its implication in designing a vaccination strategy. Oncology 2006; 70: 245–254
   PubMed Web of Science ®Google Scholar
• Frey B, Rubner Y, Wunderlich R, Weiss EM, Pockley AG, Fietkau R, et al. Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation – Implications for cancer therapies. Curr Med Chem 2012; 19: 1751–1764
   PubMed Web of Science ®Google Scholar
• Li X, Gao XH, Jin L, Wang Y, Hong Y, McHepange UO, et al. Local hyperthermia could induce migrational maturation of Langerhans cells in condyloma acuminatum. J Dermatol Sci 2009; 54: 121–123
   PubMed Web of Science ®Google Scholar
• Chen T, Guo J, Han C, Yang M, Cao X. Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway. J Immunol 2009; 182: 1449–1459
   PubMed Web of Science ®Google Scholar
• Kim JY, Son YO, Park SW, Bae JH, Chung JS, Kim HH, et al. Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation. Exp Mol Med 2006; 38: 474–484
   PubMed Web of Science ®Google Scholar
• Kubes J, Svoboda J, Rosina J, Starec M, Fiserova A. Immunological response in the mouse melanoma model after local hyperthermia. Physiol Res 2008; 57: 459–465
   PubMed Web of Science ®Google Scholar
• Stehlin JS, Giovanella BC, de Ipolyi PD, Muenz LR, Anderson RF. Results of hyperthermic perfusion for melanoma of the extremities. Surg Gynecol Obstet 1975; 140: 339–348
   PubMedGoogle Scholar
• Nakayama J, Moroi Y, Toshitani A, Taniguchi S, Okamoto-Inoue M, Hori Y. Responses of B16 melanoma cell lines, F1 and F10, to hyperthermia, lymphokine-activated killer cells and a combination of both in vitro. Br J Dermatol 1992; 126: 131–136
   PubMed Web of Science ®Google Scholar
• Nakayama J, Urabe A, Terao H, Taniguchi S, Hori Y. In situ detection of immunocompetent cells in murine B16 melanoma locally treated with interleukin-2 or microwaval hyperthermia. Pigment Cell Res 1993; 6: 111–116
   PubMedGoogle Scholar
• Nakayama J, Toyofuku K, Urabe A, Taniguchi S, Hori Y. A combined therapeutic modality with hyperthermia and locally administered rIFN-beta inhibited the growth of B16 melanoma in association with the modulation of cellular infiltrates. J Dermatol Sci 1993; 6: 240–246
   PubMedGoogle Scholar
• Strauch ED, Fabian DF, Turner J, Lefor AT. Combined hyperthermia and immunotherapy treatment of multiple pulmonary metastases in mice. Surg Oncol 1994; 3: 45–52
   PubMed Web of Science ®Google Scholar
• Frey B, Schildkopf P, Rodel F, Weiss EM, Munoz LE, Herrmann M, et al. AnnexinA5 renders dead tumor cells immunogenic-implications for multimodal cancer therapies. J Immunotoxicol 2009; 6: 209–216
   PubMed Web of Science ®Google Scholar
• Zhang HG, Mehta K, Cohen P, Guha C. Hyperthermia on immune regulation: A temperature's story. Cancer Lett 2008; 271: 191–204
   PubMed Web of Science ®Google Scholar
• Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: A randomised phase 3 multicentre study. Lancet Oncol 2010; 11: 561–570
   PubMed Web of Science ®Google Scholar
• Szmigielski S, Sobczynski J, Sokolska G, Stawarz B, Zielinski H, Petrovich Z. Effects of local prostatic hyperthermia on human NK and T cell function. Int J Hyperthermia 1991; 7: 869–880
   PubMed Web of Science ®Google Scholar
• Ostapenko VV, Tanaka H, Miyano M, Nishide T, Ueda H, Nishide I, et al. Immune-related effects of local hyperthermia in patients with primary liver cancer. Hepatogastroenterology 2005; 52: 1502–1506
   PubMedGoogle Scholar
• Atanackovic D, Nierhaus A, Neumeier M, Hossfeld DK, Hegewisch-Becker S. 41.8 degrees C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases. Cancer Immunol Immunother 2002; 51: 603–613
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Yamamoto N, Hagiwara S, Saito M, Furue H, Shigetomi T, et al. Optimization of hyperthermia and dendritic cell immunotherapy for squamous cell carcinoma. Oncol Rep 2011; 25: 1525–1532
   PubMed Web of Science ®Google Scholar
• van der Zee J, Gonzalez GD. The Dutch Deep Hyperthermia Trial: Results in cervical cancer. Int J Hyperthermia 2002; 18: 1–12
   PubMed Web of Science ®Google Scholar
• Belli F, Testori A, Rivoltini L, Maio M, Andreola G, Sertoli MR, et al. Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: Clinical and immunologic findings. J Clin Oncol 2002; 20: 4169–4180
   PubMed Web of Science ®Google Scholar
• Li Z, Qiao Y, Liu B, Laska EJ, Chakravarthi P, Kulko JM, et al. Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia. Clin Cancer Res 2005; 11: 4460–4468
   PubMed Web of Science ®Google Scholar
• Srivastava PK, Callahan MK, Mauri MM. Treating human cancers with heat shock protein-peptide complexes: The road ahead. Expert Opin Biol Ther 2009; 9: 179–186
   PubMed Web of Science ®Google Scholar
• Testori A, Richards J, Whitman E, Mann GB, Lutzky J, Camacho L, et al. Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: The C-100-21 Study Group. J Clin Oncol 2008; 26: 955–962
   PubMed Web of Science ®Google Scholar
• Hilf N, Singh-Jasuja H, Schild H. The heat shock protein Gp96 links innate and specific immunity. Int J Hyperthermia 2002; 18: 521–533
   PubMed Web of Science ®Google Scholar
• Wood C, Srivastava P, Bukowski R, Lacombe L, Gorelov AI, Gorelov S, et al. An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: A multicentre, open-label, randomised phase III trial. Lancet 2008; 372: 145–154
   PubMed Web of Science ®Google Scholar
• Srivastava PK, Old LJ. Individually distinct transplantation antigens of chemically induced mouse tumors. Immunol Today 1988; 9: 78–83
   PubMedGoogle Scholar